{{Rsnum
|rsid = 11836796
|geno1 = (C;C)
|geno2 = (C;T)
|geno3 = (T;T)
|Gene = CEP290
|Orientation=plus
|ReferenceAllele=A
|Chromosome=12
|position=88092734
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=CEP290
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 0.0 | 100.0
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

{{Venter SNP
|rsid=11836796
|allele=C
|frequency=0
|uid=1103649501611
|type=heterozygous_SNP
|hugo=CEP290
|ensembl gene=ENSG00000198707
|ensembl transcript=ENST00000309041
|sift=TOLERATED
|disease=Antibodies against Cep290 are present in sera from patients with cutaneous T-cell lymphomas, but not in the healthy control population.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}